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ABSTRACT
Objectives: The main aim of this study is to compare the oronasal and nasal spirometry among adenoid hypertrophy children before and after surgery.
Methods: A total of 40 healthy and 40 adenoid hypertrophy children were recruited for this study with the age range from 6 to 15 years. All the 
children were examined by two measurements (1) oronasal spirometry and (2) nasal spirometry. Forced vital capacity (FVC), forced expiratory 
volume in 1 s (FEV 1), FEV 1/FVC%, forced expiratory time (FET), peak expiratory flow rate, peak inspiratory flow rate (PIFR), and forced expiratory 
flow (FEF)25-75, FEF25%, FEF50%, FEF75%, FIF25%, FIF50%, and FIF75% were recorded.
Results: All the parameters were significantly reduced in adenoid hypertrophy by nasal spirometry when compared to oronasal spirometry. FEV1/
FVC% was insignificant from oral to nasal values among adenoid hypertrophy in both the sexes. FET can act as an indicator for upper airway 
obstruction which shown significantly in adenoid hypertrophy but insignificant among control and adenoidectomy. Inspiratory parameters also had 
shown more variation in nasal than oronasal spirometry.
Conclusion: Significant differences were found in many parameters between oronasal and nasal spirometry among adenoids and adenoidectomy. 
Nasal spirometry is a portable one, simple, and less cost-effective and so it can be used to determine the obstruction in the nose nasopharynx region.
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INTRODUCTION
An adenoid is the lymph tissue and is located on the upper airway 
between the nose and the back of the throat. Adenoids are the part of 
the immune system, and it fights against an infection thereby it protects 
the body. As the child grows, adenoids get regressed. In the adult 
stage, it completely disappears [1]. Due to bacterial or viral infections 
or any allergic reactions, adenoids can cause sometimes enlarged or 
swollen. Adenoid hypertrophy can cause discomfort to the children 
by obstructing the nasopharynx region. Adenoid hypertrophy children 
usually have symptoms with nasal airway obstruction, obstructed 
breathing during sleep, snoring, and open mouth breathing [2].
Several methods are available to assess adenoid hypertrophy. Palpation, 
mirror examination, X-ray, endoscopy, magnetic resonance, and acoustic 
rhinometry are the methods to accessible for determining the size of 
adenoid hypertrophy [3]. Among these, lateral neck X-ray and flexible 
fiberoptic nasal endoscopy are the two most common measurement 
tools used by the clinicians. Adenoid-nasopharyngeal ratio was 
obtained by lateral neck X-ray method which was also commonly used 
to determine the size of adenoids [4].
Since in both methods, children have to be exposed to radiation and 
endoscopy. Hence, the children feel uncomfortable while performing 
these tests. Spirometry is a non-invasive method, and it can also be used 
to evaluate the upper airway obstruction [5]. Few studies have been 
done on adenoidectomy using conventional spirometry. In conventional 
spirometry itself, researchers found some improvements in selected 
parameters before and after surgery. Based on the literature survey, 
none of the research was done on adenoids using spirometry.
It is evident that there is no simple and well-organized method 
to evaluate the obstruction of the nose-nasopharynx region. The 
electronic spirometer suggests many parameters which are not present 
in the conventional spirometer. If air is made to flow through the nose-
nasopharynx region instead of the mouth, it is possible that different 
set parameters which help in diagnosis or assessment of obstruction in 
this region may be found. Hence, the main aim of the present study is to 
assess the nose nasopharyngeal obstruction using simple modification 
to the conventional spirometer.
METHODS
Spirometer
RMS Helios 401 spirometer, an electronic, hand-held device with 
computerized programmed was used to evaluate lung function 
parameters. The instrument records several parameters such as forced 
vital capacity (FVC), forced expiratory volume in 1 s (FEV 1), FEV1/
FVC%, forced expiratory time (FET), peak expiratory flow rate (PEFR), 
peak inspiratory flow rate, and forced expiratory flow (FEF)25-75, FEF25%, 
FEF50%, FEF75%, FIF25%, FIF50%, and FIF75% digitally in variable 
seconds and as percentages beside providing a computer recorded 
tracing. Instead of using mouthpiece in conventional spirometry, mask 
(mask no: 3) was used which covers both mouth and nose and named 
as oronasal spirometry. Mask (mask no: 2) which covers the only nose 
named as nasal spirometry.
Study participants
This study was conducted among 40 healthy and 40 adenoid 
hypertrophy children. Only those children with enlarged adenoids of 
greater than Grade 2 which was confirmed by lateral X-ray method 
were included in this study. Children with nasal polyps, nasal septum 
deviation, neurological disorder, and cardio-pulmonary disorder were 
excluded from this study. This study was approved by Institutional 
Human Ethical committee (Ref: IHEC no: 015/01/2015/IE/SU) of 
SIMATS. Before performing the test, thorough explanation of the test 
protocol was given to the parents and the participants. Parental consent 
was also acquired. All the children underwent oronasal and nasal 
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spirometry measurements with the mask over on mouth and nose and 
nose only, respectively. Both the measurements were done twice on each 
participant; 1 week before surgery and 40 days after adenoidectomy.
RESULTS
There were 34 males and 46 females were participated in this study. In 
each group, 17 males and 23 females were participated in this study. 
The mean age of Group I (control group) was 10.76 years and Group II 
(adenoid group) was 10.98 years. The analysis was carried out on 
Sigma plot 13 (Systat software, USA). The results are presented as a 
mean±standard error. One-way analysis of variance (ANOVA) followed 
by Student–Newman–Keuls method (multiple comparison procedure) 
was used to compare the lung parameters among both the groups 
by oronasal and nasal spirometry method. p<0.001 was considered 
statistically.
DISCUSSION
In oronasal spirometry, air passes through both nose and mouth, but in 
nasal spirometry, air passes only through the nose nasopharynx region. 
Hence, if there is any obstruction in this region, nasal spirometry may 
execute better results than oronasal spirometry. Since none of the 
research was established on adenoids using nasal spirometry, this 
initiated us to perform nasal spirometry on adenoids and adenoidectomy 
children. In case of adenoid hypertrophy, obstruction is seen in nose 
nasopharynx region. Hence, it affects the nasal spirometry parameters 
rather than oronasal parameters because in nasal spirometry the air 
passes only through the nose. 40 healthy and 40 adenoid hypertrophy 
children were recruited for this study. The male and female differences 
were also noticed in few parameters. This could be due to the incomplete 
mid-face development which could manipulate the size of nasopharynx 
at the time of the study.
FVC, FEV1, and FEV1% in all pairs showed a decrease in the nasal 
spirometry when compared to oronasal spirometry (Tables 1 and 2). 
FVC test depends on the maximum contraction of respiratory muscles. It 
may be thought this measurement remain unchanged in both oronasal 
and nasal methods. However, we found a significant decrease in both 
normal and adenoid children by nasal spirometry. Vagal afferents 
to the respiratory center could be a factor which contributes to this 
decrease. FEV1 shown a significant decline from control to adenoid 
group and also observed significant improvement from adenoid to 
adenoidectomy group by both the methods, but the clear view of 
obstruction was seen in nasal spirometry method. PEFR indicate the 
position of larger airways [6]. Reduction in PEFR can be observed in 
substantial enlargement of adenoids. In the present study also, there 
was a decline in adenoid group, and there was a progression seen in the 
adenoidectomy group (Tables 1 and 2) [7-9].
When compared to oronasal spirometry, nasal spirometry values 
were too less. This indicates that obstruction is more in the nose 
nasopharynx region. FEF25-75 was used as a marker for small airway 
obstruction [10] and also act as a potential spirometry variable 
in asthma severity [11]. However, in our study, FEF25-75, FEF 25%, 
50%, and 75% also shown the wide variation in nasal spirometry 
among adenoid groups but not in oronasal method and this indicates 
that FEF25-75 might be used to assess the upper airway obstruction 
(Tables 1 and 2). FET may prolong during pre-bronchodilator 
administration and airflow obstruction [12]. Our study revealed 
that FET differences are not reliable in normal and adenoidectomy 
children. However, in the case of adenoid hypertrophy, FET showed 
the significant rise in time for expiration among adenoid groups, 
particularly in nasal spirometry (Tables 1 and 2).
Airflow and lung volume reduction is seen in upper airway obstruction 
because of adenoid hypertrophy. In the case of adenoid hypertrophy, 
children feel difficulty in the inspiratory phase rather than the 
expiratory phase. Hence, it affects FIVC, FIF 25%, and FIF50% and 
there will be rise in these parameters after adenoidectomy. In our study, 
FIVC, FIF 25%, and FIF50% were observed a reduction in adenoids and 
increase after adenoidectomy (Tables 1 and 2) which was similar to 
Mitra Samareh [13].
CONCLUSION
Significant differences were found in many parameters between 
oronasal and nasal spirometry among adenoids and adenoidectomy. 
This indicates that if there is any obstruction in nose-nasopharynx 
region, it affects effectively more in nasal parameters than oronasal 
parameters. Hence, nasal spirometry may be helpful in the diagnosis of 
nose-nasopharyngeal obstruction. Nasal spirometry is a portable one, 
simple, and less cost-effective.
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Table 1: Comparison of spirometric parameters in oronasal and nasal spirometry of adenoids and post‑surgery among males (age 
6–15 years)
Variables Control Adenoids Post‑surgery
Oronasal Nasal Oronasal Nasal Oronasal Nasal
FVC 1.78±0.09 1.52±0.09* 1.47±0.07 0.93±0.06* 1.46±0.07 1.12±0.06*
FEV1 1.65±0.07 1.17±0.05* 1.27±0.06 0.81±0.06* 1.26±0.06 0.97±0.04*
FEV1/FVC% 94.26±1.91 80.07±3.79* 88.49±1.53 83.84±3.79ns 87.07±2.04 88.82±2.86ns
FEF25-75 1.76±0.07 1.26±0.07* 1.65±0.07 1.07±0.09* 1.64±0.07 1.24±0.07*
PEFR 2.55±0.15 1.68±0.12* 2.33±0.12 1.70±0.16* 2.33±0.12 1.98±0.15ns
FIVC 1.28±0.06 0.85±0.06* 1.23±0.09 0.60±0.04* 1.25±0.09 0.64±0.04*
FEV.5 0.99±0.02 0.61±0.04* 1.00±0.07 0.62±0.03* 1.03±0.07 0.66±0.03*
PIFR 1.66±0.05 0.94±0.05* 1.28±0.03 0.91±0.07* 1.28±0.03 1.02±0.07*
FEF25% 2.59±0.12 1.90±0.09* 1.95±0.10 1.07±0.06* 2.32±0.12 1.63±0.07*
FEF50% 2.09±0.08 1.61±0.07* 1.64±0.06 1.11±0.06* 1.75±0.06 1.47±0.07*
FEF75% 1.80±0.09 1.42±0.05* 1.51±0.07 0.94±0.05* 1.61±0.08 1.37±0.05ns
FET 1.26±0.08 1.38±0.09ns 1.03±0.06 1.81±0.15* 1.00±0.04 1.14±0.03ns
FIF25% 1.10±0.09 0.80±0.07ns 1.45±0.08 0.94±0.10* 1.46±0.08 1.12±0.09*
FIF50% 1.84±0.10 1.27±0.10* 1.45±0.03 0.63±0.04* 1.49±0.03 0.74±0.04*
Data expressed as mean±SE. FVC: Forced vital capacity, FEV1: Forced expiratory volume in first seconds, FEV1%: Percentage of FVC expired in first seconds, FEF25-75: 
Forced expiratory flow rate in 25-75, PEFR: Peak expiratory flow rate, FIVC: Forced inspiratory vital capacity, FEF 25%: Forced expiratory flow between 25% of expired 
volume during FVC test, FEF 25%: Forced expiratory flow between 25% of expired volume during FVC test, FEF 50%: Forced expiratory flow between 50% of expired 
volume during FVC test, FEF 75%: Forced expiratory flow between 75% of expired volume during FVC test, FET: Forced expiratory time, PIFR: Peak inspiratory flow 
rate, FIF 25%: Forced inspiratory flow at 25% of FIVC, FIF 50%: Forced inspiratory flow at 50% of FIVC, SE: Standard error. *Statistically significant differences from oral 
values (p<0.001). nsStatistically nonsignificant differences from oral values (p<0.001)
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Table 2: Comparison of spirometric parameters in oronasal and nasal spirometry of adenoids and post‑surgery among females (age 
6–15 years)
Variables Control Adenoids Post‑surgery
Oronasal Nasal Oronasal Nasal Oronasal Nasal
FVC 1.64±0.07 1.67±0.12ns 1.08±0.05 0.98±0.06ns 1.09±0.05 1.20±0.08ns
FEV1 1.47±0.07 1.50±0.13* 1.02±0.04 0.71±0.02* 1.04±0.04 0.94±0.04*
FEV1/FVC% 93.81±2.71 93.55±2.10ns 93.95±1.32 72.30±2.77ns 95.49±1.10 82.76±2.72*
FEF25-75 2.54±0.32 1.80±0.24* 1.44±0.02 0.63±0.01* 1.45±0.02 0.97±0.04ns
PEFR 3.02±0.36 2.13±0.27* 1.83±0.04 0.76±0.03* 1.86±0.03 1.29±0.03ns
FIVC 1.59±0.06 1.41±0.11* 1.08±0.02 0.77±0.01* 1.02±0.02 0.82±0.01*
FEV.5 1.20±0.08 0.99±0.13* 0.80±0.01 0.37±0.01* 0.82±0.01 0.41±0.01*
PIFR 2.03±0.09 1.32±0.12* 1.63±0.10 0.75±0.02* 1.65±0.10 1.02±0.02*
FEF25% 3.19±0.38 2.15±0.26* 1.86±0.10 0.94±0.12* 2.12±0.17 1.65±0.19ns
FEF50% 2.77±0.34 2.07±0.23ns 1.86±0.15 0.93±0.08* 2.12±0.19 1.73±0.18ns
FEF75% 1.82±0.16 1.69±0.17ns 1.49±0.13 0.98±0.10* 1.55±0.14 1.51±0.16ns
FET 1.33±0.11 1.43±0.15ns 1.04±0.08 1.55±0.11* 1.04±0.07 1.19±0.06ns
FIF25% 1.79±0.09 1.14±0.07* 1.08±0.12 0.44±0.02* 1.10±0.12 0.49±0.02*
FIF50% 1.46±0.04 0.94±0.04* 1.41±0.07 0.86±0.08* 1.39±0.07 0.97±0.08*
Data expressed as mean±SE. FVC: Forced vital capacity, FEV1: Forced expiratory volume in first seconds, FEV1%: Percentage of FVC expired in first seconds, FIVC: 
Forced inspiratory vital capacity, FEF25-75: Forced expiratory flow rate in 25–75, PEFR: Peak expiratory flow rate, FIVC: Forced inspiratory vital capacity, FEF 25%: Forced 
expiratory flow between 25% of expired volume during FVC test, FEF 25%: Forced expiratory flow between 25% of expired volume during FVC test, FEF 50%: Forced 
expiratory flow between 50% of expired volume during FVC test, FEF 75%: Forced expiratory flow between 75% of expired volume during FVC test, FET: Forced 
expiratory time, PIFR: Peak inspiratory flow rate, FIF 25%: Forced inspiratory flow at 25% of FIVC, FIF 50%: Forced inspiratory flow at 50% of FIVC. *Statistically 
significant differences from oral values (p<0.001). nsStatistically nonsignificant differences from oral values (p<0.001)
